These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25928624)

  • 1. Consensus clinical management guidelines for Friedreich ataxia.
    Corben LA; Lynch D; Pandolfo M; Schulz JB; Delatycki MB;
    Orphanet J Rare Dis; 2014 Nov; 9():184. PubMed ID: 25928624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases.
    Corben LA; Collins V; Milne S; Farmer J; Musheno A; Lynch D; Subramony S; Pandolfo M; Schulz JB; Lin K; Delatycki MB;
    Orphanet J Rare Dis; 2022 Nov; 17(1):415. PubMed ID: 36371255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friedreich ataxia: clinical features and new developments.
    Keita M; McIntyre K; Rodden LN; Schadt K; Lynch DR
    Neurodegener Dis Manag; 2022 Oct; 12(5):267-283. PubMed ID: 35766110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friedreich ataxia: the clinical picture.
    Pandolfo M
    J Neurol; 2009 Mar; 256 Suppl 1():3-8. PubMed ID: 19283344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Both Sides of the Wheelchair": The Views of Individuals with, and Parents of Individuals with Friedreich Ataxia Regarding Pre-symptomatic Testing of Minors.
    Lowe GC; Corben LA; Duncan RE; Yoon G; Delatycki MB
    J Genet Couns; 2015 Oct; 24(5):732-43. PubMed ID: 25592143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical neurogenetics: friedreich ataxia.
    Collins A
    Neurol Clin; 2013 Nov; 31(4):1095-120. PubMed ID: 24176426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friedreich Ataxia: Diagnostic Yield and Minimal Frequency in South Brazil.
    Fussiger H; Saraiva-Pereira ML; Leistner-Segal S; Jardim LB
    Cerebellum; 2019 Feb; 18(1):147-151. PubMed ID: 29938355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia.
    Profeta V; McIntyre K; Wells M; Park C; Lynch DR
    Expert Opin Investig Drugs; 2023 Jan; 32(1):5-16. PubMed ID: 36708320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milestones in Friedreich ataxia: more than a century and still learning.
    Abrahão A; Pedroso JL; Braga-Neto P; Bor-Seng-Shu E; de Carvalho Aguiar P; Barsottini OG
    Neurogenetics; 2015 Jul; 16(3):151-60. PubMed ID: 25662948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friedreich ataxia in Acadian families from eastern Canada: clinical diversity with conserved haplotypes.
    Richter A; Poirier J; Mercier J; Julien D; Morgan K; Roy M; Gosselin F; Bouchard JP; Melançon SB
    Am J Med Genet; 1996 Sep; 64(4):594-601. PubMed ID: 8870928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voice in Friedreich Ataxia.
    Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
    J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of the Friedreich Ataxia Impact Scale.
    Tai G; Yiu EM; Corben LA; Delatycki MB
    J Neurol Sci; 2015 May; 352(1-2):53-7. PubMed ID: 25840637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing phase II clinical trials in Friedreich ataxia.
    Rodden LN; Lynch DR
    Expert Opin Emerg Drugs; 2021 Dec; 26(4):415-423. PubMed ID: 34693848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell and gene therapy for Friedreich ataxia: progress to date.
    Evans-Galea MV; Pébay A; Dottori M; Corben LA; Ong SH; Lockhart PJ; Delatycki MB
    Hum Gene Ther; 2014 Aug; 25(8):684-93. PubMed ID: 24749505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.
    Lodi R; Cooper JM; Bradley JL; Manners D; Styles P; Taylor DJ; Schapira AH
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11492-5. PubMed ID: 10500204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and Language Disorders in Friedreich Ataxia: Highlights on Phenomenology, Assessment, and Therapy.
    Schirinzi T; Sancesario A; Bertini E; Castelli E; Vasco G
    Cerebellum; 2020 Feb; 19(1):126-130. PubMed ID: 31701351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Onset Friedreich's Ataxia With Oculomotor Apraxia.
    Saghazadeh A; Hafizi S; Hosseini F; Ashrafi MR; Rezaei N
    Acta Med Iran; 2017 Feb; 55(2):128-130. PubMed ID: 28282710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular studies in five Brazilian cases of Friedreich ataxia.
    Schwartz IV; Jardim LB; Puga AC; Cocozza S; Leistner S; Lima LC
    Arq Neuropsiquiatr; 1999 Mar; 57(1):1-5. PubMed ID: 10347715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three clinical rating scales in Friedreich ataxia (FRDA).
    Bürk K; Mälzig U; Wolf S; Heck S; Dimitriadis K; Schmitz-Hübsch T; Hering S; Lindig TM; Haug V; Timmann D; Degen I; Kruse B; Dörr JM; Ratzka S; Ivo A; Schöls L; Boesch S; Klockgether T; Klopstock T; Schulz JB
    Mov Disord; 2009 Sep; 24(12):1779-84. PubMed ID: 19562766
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.